Table 1.

Baseline clinicopathologic characteristics of patients who received PIPAC

Malignancy; n (%)	Gastric cancer	9 (60.0%)
	Ovarian cancer	6 (40%)
Median PCI score (Q1; Q3);	Before PIPAC	8 (4; 15)
	After PIPAC	5 (1; 16)
Sex; n (%)	Female (n; %)	11 (73.3%)
	Male (n; %)	4 (26.7%)
Median age (Q1; Q3); years		58 (51; 68)
Median hospitalization (Q1; Q3); days		5 (3; 6)
Median BMI (Q1; Q3)		25 (20; 30)
History of radical surgery for primary tumor; (n; %)	Yes	8 (53.3%)
	No	7 (46.7%)
Median CA125 level (Q1; Q3); kIU/l		103 (15; 351)
Median CEA level (Q1; Q3); ng/l		1.4 (0.5; 9.6)
Median CA19.9 level (Q1; Q3); ng/l		12.3 (6.9; 75.9)
Number of PIPAC procedures	1	5 (33.3%)
	2	2 (13.3%)
	3–4	8 (53.4%)
Median operation time (Q1; Q3); min minutes		115 (110; 133)